The patient is a 3 year old female who presented to her primary care practitioner for a well child examination and was found to have a palpable left abdominal mass. She was referred to the University of Michigan for consultation with Pediatric - PowerPoint PPT Presentation

1 / 80
About This Presentation
Title:

The patient is a 3 year old female who presented to her primary care practitioner for a well child examination and was found to have a palpable left abdominal mass. She was referred to the University of Michigan for consultation with Pediatric

Description:

The patient is a 3 year old female who presented to her primary care practitioner for a well child e – PowerPoint PPT presentation

Number of Views:362
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: The patient is a 3 year old female who presented to her primary care practitioner for a well child examination and was found to have a palpable left abdominal mass. She was referred to the University of Michigan for consultation with Pediatric


1
The patient is a 3 year old female who presented
to her primary care practitioner for a well child
examination and was found to have a palpable left
abdominal mass. She was referred to the
University of Michigan for consultation with
Pediatric Hematology-Oncology. Abdominal
ultrasound and follow up CT showed an
approximately 7 cm left renal mass in the lower
pole of the kidney. A smaller periaortic mass was
also noted. Laboratory studies showed normal
uric acid, alpha fetoprotein, beta HCG, CEA, and
urinary catecholamines. Her LDH was slightly
elevated. She subsequently underwent a left
radical nephrectomy and periaortic lymph node
dissection. The virtual slide is from the
nephrectomy specimen.
2
(No Transcript)
3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
(No Transcript)
10
(No Transcript)
11
(No Transcript)
12
Case 12 Diagnosis
  • Left renal mass, nephrectomy (163 gm)
  • Nephroblastoma (Wilms tumor), 6.7 cm in greatest
    dimension, with diffuse anaplasia.
  • Tumor involves renal sinus vessels.
  • Tumor penetrates the renal capsule, and is
    focally present at the inked surgical margin
    (local pathologic stage 3).

13
Introduction to Wilms tumorand high risk renal
tumors
  • Robert E. Ruiz, M.D., Ph.D.
  • University of Michigan
  • Ann Arbor, MI

14
Outline
  • General characteristics of Wilms tumor
  • Anaplasia in Wilms tumor
  • Childrens Oncology Group
  • Brief overview of other high risk tumors
  • Practical Considerations
  • Processing pediatric renal tumors
  • Signing out pediatric renal tumors

15
1. General characteristics of Wilms tumor
16
Nephroblastoma (Wilms tumor)
  • One of the most common malignant solid tumors of
    childhood (extracranial), accounting for about 8
    of pediatric malignancies
  • Approximately 1/10,000 children (Blacks
    gtWhitesgtAsians)
  • Accounts for 80 of primary renal tumors in
    children

17
(No Transcript)
18
from AFIP Atlas of Tumor Pathology, 3rd Series,
Fascicle 11
19
Nephroblastoma (Wilms tumor)Gross features
  • Usually solitary, rounded masses
  • Multicentric 12 - 15
  • Bilateral 5 - 6
  • Size 60 - 6350 gm median 550 gm
  • Pale tan or gray, pseudocapsule, bulging cut
    surface, generally soft
  • Lobulation, cysts, hemorrhage, necrosis possible

20
External surface
Cross-section of mass
Typical Wilms tumor gross appearance
21
Nephroblastoma (Wilms tumor)Microscopic features
  • Histologically quite diverse
  • Typical pattern is triphasic pattern
  • Blastema (Metanephric)
  • Epithelium
  • Stroma

22
Nephroblastoma (Wilms tumor)Microscopic features
(contd.)
  • Triphasic is classic pattern, but monophasic or
    biphasic pattern also possible
  • If one component comprises greater than 2/3 of
    tumor, designate accordingly
  • Mixed (no component predominates) - 41
  • Blastema-predominant - 39
  • Epithelium-predominant - 18
  • Stroma-predominant - 1.4

23
What does term blastema mean?
24
5th week
Blastema resembles the metanephric mesoderm
from Langmans Medical Embryology
25
Kidney from 17 week fetus
26
Cortical neogenic zone
27
Wilms tumor Blastema
28
Wilms tumor Epithelium - tubules
29
Wilms tumor Epithelium - glomeruli
30
Primitive mesenchyme surrounding collecting system
31
Triphasic Wilms tumor
32
2. Anaplasia in Wilms tumor
33
Favorable vs. unfavorable histology
  • Terminology reflects interest in histologic
    classification that provides prognostic
    information
  • Usually used in reference to Wilms tumor and
    neuroblastoma
  • Conclusion is based on different criteria in
    these two tumors
  • In Wilms tumor, distinction between favorable and
    unfavorable histology is based upon anaplasia

34
Anaplasia
  • Two histologic features (seen with 10x objective)
  • Markedly enlarged, hyperchromatic nuclei (at
    least 3-fold increase in nuclear diameter)
  • Multipolar mitotic figures (correlate with
    polyploid chromosomal content)

35
Anaplasia
36
Anaplasia
37
Anaplasia
  • Most important prognostic histologic feature in
    Wilms tumor
  • Appears to be correlated with response or
    resistance to therapy
  • When widely distributed (diffuse) is associated
    with worse prognosis than when localized (focal)
  • Anaplastic Wilms is a high risk renal tumor

38
from Faria P, et al. Am J Surg Pathol 20
909-920, 1996
39
from Faria P, et al. Am J Surg Pathol 20
909-920, 1996
40
Case 12 Markedly enlarged, hyperchromatic nuclei
41
Case 12 Multipolar mitotic figures
42
How does this impact treatment?
43
3. Children's Oncology Group
44
CureSearch
  • Two components
  • Childrens Oncology Group (COG)
  • Supported by National Cancer Institute to conduct
    cooperative research and clinical trials for
    children with cancer
  • Develops and coordinates clinical trials at more
    than 240 member institutions in U.S. and Canada,
    and sites in Europe and Australia
  • National Childhood Cancer Foundation
  • Raises private funds for childhood cancer
    research carried out by the COG

45
COG
  • Formed in 2000 by merger of four pre-existing
    cooperative research and clinical trial
    organizations
  • Childrens Cancer Group (CCG)
  • Intergroup Rhabdomyosarcoma Study Group (IRSG)
  • National Wilms Tumor Study Groups (NWTSG)
  • Pediatric Oncology Group (POG)

46
COG Clinical Trials
  • Currently over 150 ongoing trials, with over
    40,000 patients receiving treatment on a COG
    protocol
  • All data about diagnosis, treatment, and results
    goes to Group Operations Center for analysis
  • Tissue samples and cell lines may be collected
    and stored for use in research
  • Laboratories important for diagnosis, treatment
    and research are also maintained
  • Research findings are shared with entire group
    and used to develop next steps and protocols

47
Kidney Tumors Committee
  • Descendant of the NWTSG, founded in 1969
  • One of the four organizations that merged to form
    COG in 2000
  • About 70 of children with Wilms tumors have been
    treated on these protocols in past 20 years
  • Cure rate has improved from 40 to 85-90, while
    decreasing the amount of chemotherapy and
    radiation therapy
  • Other renal tumors are also studied, and can
    require different treatment than Wilms
  • Biological and genetic insights are also being
    obtained

48
Current emphases
  • Low risk patients Surgery only?
  • Standard (intermediate) risk patients Continue
    to study, find ways to identify 10-15 who recur
  • High risk patients Less than 75 cure rate with
    some tumors, including resistant forms of Wilms
    (anaplastic Wilms) need to develop improved
    treatments

49
AREN0321 Therapeutic approaches to high risk
pediatric renal tumors
from Perlman EJ, Ped Dev Pathol 8 320-338, 2005
50
4. Non-Wilms high risk renal tumors
51
Clear cell sarcoma of kidney
  • Bone metastasizing renal tumor of childhood
  • Comprises 4 of primary pediatric renal tumors
  • Predilection for metastasis to bone and numerous
    other sites, including LN, brain, lungs, liver,
    skeletal muscle, soft tissues

52
from AFIP Atlas of Tumor Pathology, 3rd Series,
Fascicle 11
53
Clear cell sarcoma of kidneyGross features
  • Solitary, unilateral masses
  • Size 126 - 3000 gm median 520 gm
  • Usually arise from medullary or central regions
    of kidney
  • Homogeneous cut surface, often mucoid
  • Mass often irregularly shaped, cystic

54
Clear cell sarcoma
55
Clear cell sarcoma of kidneyMicroscopic features
  • Homogeneous, pale blue appearance
  • Many histologic patterns
  • Most have classic pattern monomorphous,
    forming cords or nests (6 - 10 cells wide) of
    cells with clear cytoplasm, uniform, finely
    granular to empty nuclei, and inconspicuous
    nucleoli, separated by thin vascular septa, often
    with infiltrative margins and entrapped renal
    elements

56
Low magnification
57
Cystic areas
58
Rhabdoid tumor
  • Comprises 2 of primary pediatric renal tumors
  • Association with separate intracranial primitive
    neuroepithelial tumors has been seen in 15 of
    cases
  • Very aggressive neoplasm with early dissemination
    and wide metastasis, hematogenous and lymphatic

59
from AFIP Atlas of Tumor Pathology, 3rd Series,
Fascicle 11
60
Rhabdoid tumorGross features
  • Generally unicentric, unilateral, but multiple
    nodules representing 2 implants possible
  • Size lt 500 gm
  • Smaller tumors arise in medulla
  • Pale, soft, bulging cut surface
  • Relatively well demarcated from kideny, but
    generally no capsule

61
Rhabdoid tumor
62
Rhabdoid tumorMicroscopic features
  • Sheets of monomorphous, large, loosely cohesive
    cells with large, vesicular nuclei, prominent
    nucleoli, abundant eosinophilic cytoplasm,
    distinct cell borders
  • Characteristic cytoplasmic inclusions not present
    in all cases, tend to be clustered rather than
    diffuse

63
Rhabdoid tumor
64
Lymphovascular invasion common, unencapsulated
65
Rhabdoid morphology
66
Rhabdoid tumor
  • Characteristic feature is mutation or deletion of
    hSNF1/INI1 gene (chromosome 22q11.2, 80)
  • Immunohistochemistry gives variable results, but
    can be helpful
  • INI-1 - negative
  • Vimentin, cytokeratins - positive
  • EMA - usually positive
  • Desmin, actin - sometimes positive
  • Electron microscopy prominent aggregates of
    filaments form tightly whorled structures next to
    nucleus

67
Renal epithelial tumors
  • Overall, more than 5 of pediatric renal tumors
  • Two predominant groups
  • Clear cell carcinomas, in particular the
    translocation associated carcinomas TFE3 gene
    at Xp11, PRCC gene on chromosome 1
  • Papillary carcinomas same genetic features as
    in adults (gains of chromosomes 7, 17), and
    cytokeratin 7 positivity by IHC

68
5. Practical considerations
  • Processing pediatric renal tumors
  • Signing out pediatric renal tumors

69
Renal tumor processing
  • Initial processing of fresh specimen should
    emphasize obtaining tissue for special studies.
  • Snap frozen tumor and normal kidney (for
    determination of LOH for 1p or 16q - this is for
    FH Wilms protocols)
  • Cytogenetics (if untreated tumor should cancel
    if signed out as Wilms)

70
  • Fresh specimen
  • Always weigh the specimen
  • Always measure overall dimensions and tumor
    size
  • Always photograph uncut specimen, describe
    any defects in capsule
  • Ink surface and bivalve
  • Always photograph cut surface
  • If thick, add additional cuts parallel to
    bivalve, so slices no more than 1 cm thick
  • Put gauze or paper towel between all slices
    to fix
  • For renal PTP, need to take fresh and snap
    freeze
  • Two samples of tumor
  • Two samples of uninvolved kidney

71
Samples for cytogenetics and snap freezing, from
either a resection specimen or a reasonably
large biopsy (greater than 1 cm3 ), should be
about the size of a standard pencil eraser.
72
Sectioning the pediatric renal tumor
  • Take standard ureteral and vascular margins. Look
    for tumor thrombus in the renal vein.
  • Use photographs or diagrams of the tumor to map
    sections! This is important for the distinction
    between focal and diffuse anaplasia.
  • Fix the tumor in abundant formalin. Wilms tumors
    are often very friable, and optimal histologic
    evaluation depends upon excellent fixation.

73
Sectioning the pediatric renal tumor
  • Sections for histologic review must provide
    information about morphology, anaplasia, and
    staging
  • Sample the nephrectomy resection margins
    (superior, inferior, medial, lateral, anterior,
    and posterior). Describe sections in gross
    description refer to map inadequate if map is
    lost
  • Extensively sample the renal sinus (area
    immediately around the pelvis, including soft
    tissue and vessels). Very important to consider
    extensions of sinus into the kidney.
  • Sample interface of intrarenal tumor capsule,
    extrarenal tumor capsule, renal capsule.

74
Sectioning the pediatric renal tumor (contd)
  • Additional sections should emphasize the
    periphery of the mass, as tumor is most likely to
    be viable there, and information about the
    tumor/kidney interface (e.g., well-circumscribed
    vs. infiltrative) and the possibility of
    nephrogenic rests can be obtained.
  • Approximately 1 cassette per cm of tumor greatest
    dimension should be submitted.
  • Any hilar lymph nodes should be sampled.
  • Uninvolved kidney should also be sampled (1
    cassette).

75
  • Always sample
  • Ureteral and vascular margins
  • Nephrectomy resection margins
  • Area of renal sinus
  • Interface of external tumor capsule, internal
    tumor capsule, renal capsule (triangular section
    in diagram)
  • 5. Periphery of mass
  • 6. Normal kidney

76
Signing out pediatric renal tumors
  • Always need to include
  • Type of tumor
  • Weight of nephrectomy specimen
  • Intactness of capsule grossly
  • Greatest dimension of tumor
  • Favorable vs. unfavorable histology
  • Focal vs. diffuse anaplasia (if applicable)
  • Margin status
  • Local pathologic stage, with details of
    determining features

77
Signing out pedi
Signing out pediatric renal tumors
  • Stage I Tumor is confined to the kidney and
    completely resected capsule intact, no previous
    biopsy, renal sinus not involved
  • Stage II Tumor extends beyond kidney, but
    completely resected penetrates renal capsule,
    extensively invades renal sinus soft tissue,
    lymphovascular invasion outside parenchyma

78
Signing out pedi
Signing out pediatric renal tumors
  • Stage III Residual tumor is present, limited to
    abdomen peritoneal implants, resection margins
    positive, previous biopsy, tumor rupture
    abdominal or pelvic lymph nodes positive
  • Stage IV Metastatic tumor present lymph nodes
    positive outside abdomen and pelvis, distant
    metastases
  • Stage V Bilateral tumor at diagnosis also need
    to stage each side individually

79
Summary
  • Reviewed the general pathologic features of Wilms
    tumor
  • Discussed the concepts of favorable vs.
    unfavorable histology, and focal vs. diffuse
    anaplasia
  • Introduced the COG and the current high risk
    pediatric renal tumor protocol
  • Briefly covered non-Wilms high risk renal tumors
  • Considered practical aspects of renal tumor
    processing and signout which will contribute to
    greater understanding and more effective
    treatment of these tumors

80
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com